Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- CURA.TO
- Price
- 2.73
- Stock movement down
- -0.14 (-3.50%)
- Company name
- Curaleaf Holdings Inc.
- Exchange
- (TO ,
- Currency
- CAD )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 2.59B
- Ent value
- -
- Price/Sales
- -
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-10-30
DIVIDENDS
CURA.TO does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | - |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 670.46M |
| EPS (TTM) | - |
| FCF per share (TTM) | - |
Income statement
Loading...
Income statement data
| Revenue (TTM) | - |
| Gross profit (TTM) | - |
| Operating income (TTM) | - |
| Net income (TTM) | - |
| EPS (TTM) | - |
| EPS (1y forward) | -0.14 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 0.00 |
| Net receivables | 59.96M |
| Total current assets | 445.92M |
| Goodwill | 631.82M |
| Intangible assets | 1.07B |
| Property, plant and equipment | 0.00 |
| Total assets | 2.95B |
| Accounts payable | 0.00 |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 316.23M |
| Total liabilities | 2.13B |
| Shareholder's equity | 814.02M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | - |
| Capital expenditures (TTM) | - |
| Free cash flow (TTM) | - |
| Dividends paid (TTM) | - |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | - |
| Return on Invested Capital | - |
| Cash Return on Invested Capital | - |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 3.95 |
| Daily high | 3.96 |
| Daily low | 3.76 |
| Daily Volume | 308K |
| All-time high | 4.64 |
| 1y analyst estimate | 4.40 |
| Beta | 1.56 |
| EPS (TTM) | - |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| CURA.TO | S&P500 | |
| Current price drop from All-time high | -41.16% | -3.97% |
| Highest price drop | -18.53% | -19.00% |
| Date of highest drop | 22 Oct 2025 | 8 Apr 2025 |
| Avg drop from high | -7.69% | -2.72% |
| Avg time to new high | 4 days | 5 days |
| Max time to new high | 15 days | 89 days |
COMPANY DETAILS
Marketcap
2.59B
Marketcap category
Mid-cap
Description
Curaleaf Holdings, Inc. produces and distributes cannabis products in the United States and internationally. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of hemp-derived THC products through wholesale channels. The company is headquartered in Stamford, Connecticut.
Employees
5519
Website
Investor relations
-
SEC filings
CEO
Country
Canada
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
CRLBF's move into Germany opens a new growth path as it navigates U.S. pricing pressure and rising competition in its core market.
November 19, 2025
Canopy Growth's narrower loss, rising Canadian sales and improving margins signal progress in its turnaround, even as competition and global headwinds persist.
November 13, 2025
As November unfolds, the Canadian market is experiencing a moment of reflection amid global equity pullbacks, largely driven by recalibrations in AI valuations. Despite these fluctuations, Canada's ec...
November 11, 2025
Key Takeaways; Cannabis Sector Trulieve Cleared Major Debt as CEO Hailed Strategic Progress and Cash Strength Curaleaf Delivered Solid Q3 with Rising Cash Flow and International Momentum Canopy Growth...
November 10, 2025
TLRY expands its global medical cannabis footprint with key launches and approvals across Panama, Germany, Italy and Australia.
November 10, 2025
TLRY's 94.5% surge, record fiscal Q1 revenues, and expanding medical cannabis footprint fuel optimism amid global challenges.
November 7, 2025
Curaleaf Holdings has seen its fair value estimate rise from CA$4.06 to CA$4.21. This reflects a modest upward adjustment based on optimistic analyst sentiment. This change comes alongside a slightly ...
November 7, 2025
Curaleaf Holdings, Inc. reported third quarter 2025 earnings with revenue of US$320.24 million and a net loss of US$57.03 million, while the company also expanded its European operations and secured a...
November 6, 2025
Curaleaf Holdings Inc (CURLF) reports steady revenue growth and international expansion, despite facing domestic retail headwinds and price compression.
November 6, 2025
Curaleaf Holdings, Inc. (CURLF) delivered earnings and revenue surprises of +14.29% and +1.04%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the...
November 5, 2025
Next page